JP Patent

JP7091494B2 — （Ｓ）－４－（８－アミノ－３－（１－（ブト－２－イノイル）ピロリジン－２－イル）イミダゾ［１，５－ａ］ピラジン－１－イル）－Ｎ－（ピリジン－２－イル）ベンザミドの固体形態及び製剤

Assigned to アセルタ ファーマ ビー．ブイ． · Expires 2022-06-27 · 4y expired

What this patent protects

Patent listed against Calquence.

Drugs covered by this patent

Patent Metadata

Patent number
JP7091494B2
Jurisdiction
JP
Classification
—
Expires
2022-06-27
Drug substance claim
No
Drug product claim
No
Assignee
アセルタ ファーマ ビー．ブイ．
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.